Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia
Mt. Collins et al., Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia, J BONE MIN, 16(5), 2001, pp. 806-813
Fibrous dysplasia (FD) of bone is characterized by focal replacement of nor
mal bone and marrow with abnormal bone and fibrous tissue. It arises from p
ostzygotic activating mutations of the GNAS1 gene. Hypophosphatemia due to
renal phosphate wasting has been reported in association with FD as a part
of the McCune-Albright Syndrome (MAS), which is characterized by FD, skin h
yperpigmentation, and precocious puberty. To date, the prevalence and mecha
nism of phosphate wasting has not been well studied. We evaluated 42 patien
ts with FD/MAS. Serum and urine samples were tested for indices of mineral
metabolism, amino acid handling, and markers of bone metabolism. Twenty (48
%) patients had some degree of renal phosphate wasting. Nephrogenous cyclic
adenosine monophosphate (cAMP) was normal in FD patients, suggesting that
the underlying cause of phosphate wasting is not the presence of activating
GNAS1 mutations in the kidney. In addition, there was evidence of a more g
eneralized renal tubulopathy as represented by the presence of abnormal vit
amin D metabolism, proteinuria in 36 (86%) patients, and aminoaciduria in 3
9 (94%) patients. Renal phosphate wasting significantly correlated with the
degree of bone involvement, as assessed by serum and urine markers of bone
metabolism, suggesting that a circulating factor produced by FD bone and i
mpacting on the kidney may be the mechanism, These data show that phosphatu
ria as part of a generalized renal tubulopathy represents the most common e
xtraskeletal manifestation of FD and that the observed tubulopathy is simil
ar to that seen in tumor-induced osteomalacia (TIO).